Published in Infect Immun on April 01, 1995
Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A (2001) 2.67
Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A (1997) 1.58
Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane. J Cell Sci (2011) 1.11
Purification and characterization of a hemolysin produced by Vibrio mimicus. Infect Immun (1997) 0.89
Imaging viral RNA using multiply labeled tetravalent RNA imaging probes in live cells. Methods (2016) 0.75
Formation of ring-shaped structures on erythrocyte membranes after treatment with botulinolysin, a thiol-activated hemolysin from Clostridium botulinum. Infect Immun (1998) 0.75
Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74
Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun (1987) 4.92
Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther (1980) 4.08
Mechanism of membrane damage by streptolysin-O. Infect Immun (1985) 3.26
Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect Immun (1987) 3.24
Binding of cholesterol by sulfhydryl-activated cytolysins. Infect Immun (1980) 3.16
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol (1993) 2.37
Damage to cell membranes by pore-forming bacterial cytolysins. Prog Allergy (1988) 2.23
Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction. J Cell Biol (1975) 2.22
Identification of the structural gene encoding the SH-activated hemolysin of Listeria monocytogenes: listeriolysin O is homologous to streptolysin O and pneumolysin. Infect Immun (1987) 2.16
Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin. Infect Immun (1988) 2.10
Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun (1993) 2.09
Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun (1989) 1.91
Interaction of steptolysin O with sterols. Biochim Biophys Acta (1976) 1.84
Nucleotide sequence of the listeriolysin gene from a Listeria monocytogenes serotype 1/2a strain. Nucleic Acids Res (1989) 1.72
Morphologic changes in the membranes of red blood cells undergoing hemolysis. Am J Med (1966) 1.70
The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun (1989) 1.63
Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine. J Bacteriol (1990) 1.44
Approximate dimensions of membrane lesions produced by streptolysin S and streptolysin O. Biochim Biophys Acta (1983) 1.41
Alteration by cereolysin of the structure of cholesterol-containing membranes. Biochim Biophys Acta (1978) 1.40
Evidence for membrane cholesterol as the common binding site for cereolysin, streptolysin O and saponin. Mol Cell Biochem (1974) 1.30
Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O. Infect Immun (1986) 1.28
Interaction of alveolysin A sulfhydryl-activated bacterial cytolytic toxin with thiol group reagents and cholesterol. Toxicon (1982) 1.13
Role of cholesterol in the action of cereolysin on membranes. Arch Biochem Biophys (1978) 1.11
Streptococcal toxins. Rev Infect Dis (1983) 1.06
Protease-nicked theta-toxin of Clostridium perfringens, a new membrane probe with no cytolytic effect, reveals two classes of cholesterol as toxin-binding sites on sheep erythrocytes. Eur J Biochem (1988) 1.02
Interaction of streptolysin-O with biomembranes: kinetic and morphological studies on erythrocyte membranes. Toxicon (1985) 1.01
Cholesterol-dependent tetanolysin damage to liposomes. Biochim Biophys Acta (1979) 0.98
Ring formation of perfringolysin O as revealed by negative stain electron microscopy. Biochim Biophys Acta (1979) 0.94
Interaction of streptolysin O from Streptococcus pyogenes and theta-toxin from Clostridium perfringens with human fibroblasts. Infect Immun (1980) 0.94
Sterol structural requirements for inhibition of streptolysin O activity. Biochem J (1974) 0.92
Survival of cultured cells after functional and structural disorganization of plasma membrane by bacterial haemolysins and phospholipases. Toxicon (1983) 0.91
Effect of isolated C-terminal fragment of theta-toxin (perfringolysin O) on toxin assembly and membrane lysis. Eur J Biochem (1990) 0.90
Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med Microbiol Immunol (1994) 0.90
Membrane disorganization induced by perfringolysin O (theta-toxin) of Clostridium perfringens--effect of toxin binding and self-assembly on liposomes. Biochim Biophys Acta (1993) 0.81
Effects of cholesterol evulsion on susceptibility to perfringolysin O of human erythrocytes. Biochim Biophys Acta (1982) 0.79
On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol (1981) 4.06
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun (1986) 3.94
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Mechanism of membrane damage by streptolysin-O. Infect Immun (1985) 3.26
Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid. J Clin Microbiol (1995) 3.04
Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A (2001) 2.67
Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes. Infect Immun (1986) 2.66
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J (1986) 2.62
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun (1994) 2.47
Staphylococcal alpha-toxin: oligomerization of hydrophilic monomers to form amphiphilic hexamers induced through contact with deoxycholate detergent micelles. Proc Natl Acad Sci U S A (1981) 2.38
A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol (1993) 2.37
Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol (1987) 2.36
Damage to cell membranes by pore-forming bacterial cytolysins. Prog Allergy (1988) 2.23
Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol (1998) 2.16
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group. Ann Intern Med (1996) 2.15
Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol (1996) 2.11
Molecular nature of the complement lesion. Proc Natl Acad Sci U S A (1978) 2.09
Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun (1993) 2.09
Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J (1995) 2.08
Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol (1985) 2.03
Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation (2001) 2.02
Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin. Infect Immun (1984) 2.01
Membrane damage by complement. Biochim Biophys Acta (1983) 2.00
Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol (1978) 1.95
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol (1995) 1.94
Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev (2004) 1.92
Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol (1986) 1.83
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
Subcytocidal attack by staphylococcal alpha-toxin activates NF-kappaB and induces interleukin-8 production. Infect Immun (2001) 1.71
Protein sorting in Plasmodium falciparum-infected red blood cells permeabilized with the pore-forming protein streptolysin O. Biochem J (1996) 1.64
Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation (2001) 1.64
Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta (1987) 1.61
Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A (1997) 1.58
Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am J Physiol (1985) 1.57
Mechanism of complement cytolysis and the concept of channel-forming proteins. Philos Trans R Soc Lond B Biol Sci (1984) 1.57
VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J (1995) 1.56
Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res (1996) 1.55
Quality-of-life assessment: patient compliance with questionnaire completion. J Natl Cancer Inst (1992) 1.55
Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet (1993) 1.52
Cervical lymph node biopsy--a study of its morbidity. J Laryngol Otol (1984) 1.49
SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol (1995) 1.48
Isolation of the terminal complement complex from target sheep erythrocyte membranes. Biochim Biophys Acta (1976) 1.47
T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J Exp Med (1991) 1.47
A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development (1996) 1.47
Complement activation by oxidatively modified low-density lipoproteins. Eur J Clin Invest (1999) 1.47
Characterization of SNARE protein expression in beta cell lines and pancreatic islets. Endocrinology (1996) 1.45
Helicobacter sp. strain Mainz isolated from an AIDS patient with septic arthritis: case report and nonradioactive analysis of 16S rRNA sequence. J Clin Microbiol (1994) 1.45
Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett (1987) 1.44
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest (1984) 1.43
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
Fatal transfusion reaction due to Yersinia enterocolitica. J Hosp Infect (1994) 1.40
Minimal requirements for exocytosis. A study using PC 12 cells permeabilized with staphylococcal alpha-toxin. J Biol Chem (1985) 1.40
Detection of amphiphilic proteins and peptides in complex mixtures. Charge-shift crossed immunoelectrophoresis and two-dimensional charge-shift electrophoresis. Biochim Biophys Acta (1977) 1.38
The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel. J Immunol (1980) 1.36
Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest (1990) 1.35
Sustained local delivery of chlorhexidine in the treatment of periodontitis: a multi-center study. J Periodontol (1997) 1.33
Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int (1986) 1.33
Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli. J Clin Microbiol (1987) 1.32
Staphylococcus aureus alpha-toxin. Dual mechanism of binding to target cells. J Biol Chem (1991) 1.30
Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect Immun (1987) 1.30
Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests. J Clin Microbiol (1996) 1.29
Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O. Infect Immun (1986) 1.28
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis immunoblotting as a serological tool in the diagnosis of syphilitic infections. J Clin Microbiol (1985) 1.27
Recovery of human fibroblasts from attack by the pore-forming alpha-toxin of Staphylococcus aureus. Microb Pathog (1994) 1.27
Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect Immun (1989) 1.27
Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem (1983) 1.26
Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes. Infect Immun (1993) 1.25
Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing. J Clin Microbiol (2000) 1.25
Sequences homologous to ZFY, a candidate human sex-determining gene, are autosomal in marsupials. Nature (1989) 1.25
Potassium regulates IL-1 beta processing via calcium-independent phospholipase A2. J Immunol (2000) 1.25
Characterization of a catalase-negative methicillin-resistant Staphylococcus aureus strain. J Clin Microbiol (2007) 1.25
Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1998) 1.23
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Antimicrob Agents Chemother (1994) 1.23
Epidermal growth factor receptor dimerization monitored in live cells. Nat Biotechnol (2000) 1.23
Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation (1997) 1.23
Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol (1997) 1.23
Cancer in Cumbria: the Windscale connection. Lancet (1984) 1.22
Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect Immun (1996) 1.22
Molecular architecture of a toxin pore: a 15-residue sequence lines the transmembrane channel of staphylococcal alpha-toxin. EMBO J (1996) 1.21
Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement. Biosci Rep (1985) 1.21
Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest (1989) 1.21